Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

An inflammatory and trophic disconnect biomarker profile revealed in Down syndrome plasma: Relation to cognitive decline and longitudinal evaluation.

Iulita MF, Ower A, Barone C, Pentz R, Gubert P, Romano C, Cantarella RA, Elia F, Buono S, Recupero M, Romano C, Castellano S, Bosco P, Di Nuovo S, Drago F, Caraci F, Cuello AC.

Alzheimers Dement. 2016 Nov;12(11):1132-1148. doi: 10.1016/j.jalz.2016.05.001. Epub 2016 Jul 21.

PMID:
27452424
2.

Abnormal Expression and Distribution of MMP2 at Initial Stages of Alzheimer's Disease-Related Pathology.

Terni B, Ferrer I.

J Alzheimers Dis. 2015;46(2):461-9. doi: 10.3233/JAD-142460.

PMID:
26402409
3.

Amyloid β Oligomers Disrupt Blood-CSF Barrier Integrity by Activating Matrix Metalloproteinases.

Brkic M, Balusu S, Van Wonterghem E, Gorlé N, Benilova I, Kremer A, Van Hove I, Moons L, De Strooper B, Kanazir S, Libert C, Vandenbroucke RE.

J Neurosci. 2015 Sep 16;35(37):12766-78. doi: 10.1523/JNEUROSCI.0006-15.2015.

4.

Plasma gelsolin and matrix metalloproteinase 3 as potential biomarkers for Alzheimer disease.

Peng M, Jia J, Qin W.

Neurosci Lett. 2015 May 19;595:116-21. doi: 10.1016/j.neulet.2015.04.014. Epub 2015 Apr 9.

PMID:
25864780
5.

Genome-wide association study of CSF levels of 59 alzheimer's disease candidate proteins: significant associations with proteins involved in amyloid processing and inflammation.

Kauwe JS, Bailey MH, Ridge PG, Perry R, Wadsworth ME, Hoyt KL, Staley LA, Karch CM, Harari O, Cruchaga C, Ainscough BJ, Bales K, Pickering EH, Bertelsen S; Alzheimer's Disease Neuroimaging Initiative, Fagan AM, Holtzman DM, Morris JC, Goate AM.

PLoS Genet. 2014 Oct 23;10(10):e1004758. doi: 10.1371/journal.pgen.1004758. eCollection 2014 Oct.

6.

A versatile omnibus test for detecting mean and variance heterogeneity.

Cao Y, Wei P, Bailey M, Kauwe JSK, Maxwell TJ.

Genet Epidemiol. 2014 Jan;38(1):51-59.

7.

Effect of proinflammatory gene polymorphisms on the risk of Alzheimer's disease.

Flex A, Giovannini S, Biscetti F, Liperoti R, Spalletta G, Straface G, Landi F, Angelini F, Caltagirone C, Ghirlanda G, Bernabei R.

Neurodegener Dis. 2014;13(4):230-6. doi: 10.1159/000353395. Epub 2013 Sep 6.

PMID:
24022074
8.

Neurodegeneration-associated protein fragments as short-lived substrates of the N-end rule pathway.

Brower CS, Piatkov KI, Varshavsky A.

Mol Cell. 2013 Apr 25;50(2):161-71. doi: 10.1016/j.molcel.2013.02.009. Epub 2013 Mar 14.

9.

Limited cleavage of tau with matrix-metalloproteinase MMP-9, but not MMP-3, enhances tau oligomer formation.

Nübling G, Levin J, Bader B, Israel L, Bötzel K, Lorenzl S, Giese A.

Exp Neurol. 2012 Oct;237(2):470-6. doi: 10.1016/j.expneurol.2012.07.018. Epub 2012 Aug 6.

PMID:
22890115
10.

Genetic analysis of genes involved in amyloid-β degradation and clearance in Alzheimer's disease.

Natunen T, Helisalmi S, Vepsäläinen S, Sarajärvi T, Antikainen L, Mäkinen P, Herukka SK, Koivisto AM, Haapasalo A, Soininen H, Hiltunen M.

J Alzheimers Dis. 2012;28(3):553-9. doi: 10.3233/JAD-2011-111109.

PMID:
22027013
11.

Identifying Tmem59 related gene regulatory network of mouse neural stem cell from a compendium of expression profiles.

Zhang L, Ju X, Cheng Y, Guo X, Wen T.

BMC Syst Biol. 2011 Sep 29;5:152. doi: 10.1186/1752-0509-5-152.

12.
13.

The role of metals in modulating metalloprotease activity in the AD brain.

Filiz G, Price KA, Caragounis A, Du T, Crouch PJ, White AR.

Eur Biophys J. 2008 Mar;37(3):315-21. doi: 10.1007/s00249-007-0244-1. Epub 2008 Feb 13. Review.

PMID:
18270696
14.
15.

Matrix metalloproteinase 3 haplotypes and dementia and Alzheimer's disease. The Rotterdam Study.

Reitz C, van Rooij FJ, de Maat MP, den Heijer T, Hofman A, Witteman JC, Breteler MM.

Neurobiol Aging. 2008 Jun;29(6):874-81. Epub 2007 Feb 20.

PMID:
17316907
16.

Robust immunohistochemical staining of several classes of proteins in tissues subjected to autolysis.

Maleszewski J, Lu J, Fox-Talbot K, Halushka MK.

J Histochem Cytochem. 2007 Jun;55(6):597-606. Epub 2007 Feb 20.

PMID:
17312010
17.

Induction of matrix metalloproteinases (MMP3, MMP12 and MMP13) expression in the microglia by amyloid-beta stimulation via the PI3K/Akt pathway.

Ito S, Kimura K, Haneda M, Ishida Y, Sawada M, Isobe K.

Exp Gerontol. 2007 Jun;42(6):532-7. Epub 2007 Jan 2.

PMID:
17198748
18.
19.

Gene expression changes by amyloid beta peptide-stimulated human postmortem brain microglia identify activation of multiple inflammatory processes.

Walker DG, Link J, Lue LF, Dalsing-Hernandez JE, Boyes BE.

J Leukoc Biol. 2006 Mar;79(3):596-610. Epub 2005 Dec 19. Erratum in: J Leukoc Biol. 2006 Aug;80(2):448. J Leukoc Biol. 2006 Aug;80(2):448.

PMID:
16365156
20.

Interaction between matrix metalloproteinase 3 and the epsilon4 allele of apolipoprotein E increases the risk of Alzheimer's disease in Finns.

Saarela MS, Lehtimäki T, Rinne JO, Hervonen A, Jylhä M, Röyttä M, Ahonen JP, Mattila KM.

Neurosci Lett. 2004 Sep 9;367(3):336-9.

PMID:
15337261

Supplemental Content

Loading ...
Support Center